Outbreak of infections with the COVID-19 virus mutation B.1.351 about four weeks after the second successful vaccination with BNT162b2

2021/04/19 by Ortloff, Andrea, Harsch, Igor Alexander
Medicine · #610 Medical sciences #B.1.351 mutation #BNT162b2 vaccine #COVID-19 #Medicine #antibody formation

paper · doi:10.3205/dgkh000387

Abstract

[for full text, please go to the a.m. URL]

Related

• Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
• Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
• Covid-19: The E484K mutation and the risks it poses
• Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
• SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021